JESSICA WILSON: Open Payments
NPI 1518528298 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,888 in 95 payments from 22 companies in 2025. Trend: 2023 $882 · 2024 $2,092 · 2025 $1,888
Food & beverage: $1,888
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $339 |
| AstraZeneca Pharmaceuticals LP | 12 | $293 |
| PFIZER INC. | 12 | $214 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $153 |
| Novo Nordisk Inc | 7 | $140 |
| Lilly USA, LLC | 7 | $121 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Almatica Pharma LLC | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $61 |
Products named: FARXIGA, VRAYLAR, CAPLYTA, ELIQUIS, UBRELVY, MOUNJARO, REXULTI, BREZTRI.
Industry payments across AL — which companies pay providers there.
